Until now, big data has largely been applied to the commercial world, predicting human interactions and behaviors. Imagine if the same principles of big data in the commercial world applied to the medical world — driving research hypotheses, treatment protocols, and medical outcomes. This very idea powers the TPIRC clinical care and research model. TPIRC truly is where big data meets big medicine.
Heading our research facility is Dr. Marsteller, a molecular biologist with an emphasis on immunology and pulmonology. He has four main areas of interest. First, he studies bronchopulmonary dysplasia and noninvasive ventilation strategies and their effects and lung development at the structural and genetic level.
Second, he works to identify patients with cystic fibrosis that are at high risk for significant decline in lung function which will enable address of potential therapeutic remission, modalities, environmental exposures, and behavioral variants that may improve outcomes in these patients. Third, Dr. Marsteller is focused on the immune system, specifically food allergies and how the gut microbiota stimulates the immune system and how these interactions impact the development of food allergies. Fourth, he has spearheaded the launch of the TPIRC Biobank which allows characterizing all of these different aspects by studying the immune response of our patients with the goal of helping our patients today!